Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 37,526Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 241Amgen Inc

02 30Dompe Farmaceutici

03 2Hetero Biopharma

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : VIAL; INTRAVENOUS

Dosage Strength : 25UG/ML

Packaging :

Approval Date :

Application Number : 103951

Regulatory Info :

Registration Country : USA

blank

02

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : VIAL; INTRAVENOUS

Dosage Strength : 40UG/ML

Packaging :

Approval Date :

Application Number : 103951

Regulatory Info :

Registration Country : USA

blank

03

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : VIAL; INTRAVENOUS

Dosage Strength : 60UG/ML

Packaging :

Approval Date :

Application Number : 103951

Regulatory Info :

Registration Country : USA

blank

04

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : VIAL; INTRAVENOUS

Dosage Strength : 100UG/ML

Packaging :

Approval Date :

Application Number : 103951

Regulatory Info :

Registration Country : USA

blank

05

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : VIAL; INTRAVENOUS

Dosage Strength : 200UG/ML

Packaging :

Approval Date :

Application Number : 103951

Regulatory Info :

Registration Country : USA

blank

06

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : VIAL; SUBCUTANEOUS

Dosage Strength : 25UG/ML

Packaging :

Approval Date :

Application Number : 103951

Regulatory Info :

Registration Country : USA

blank

07

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : VIAL; SUBCUTANEOUS

Dosage Strength : 40UG/ML

Packaging :

Approval Date :

Application Number : 103951

Regulatory Info :

Registration Country : USA

blank

08

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : VIAL; SUBCUTANEOUS

Dosage Strength : 60UG/ML

Packaging :

Approval Date :

Application Number : 103951

Regulatory Info :

Registration Country : USA

blank

09

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : VIAL; SUBCUTANEOUS

Dosage Strength : 100UG/ML

Packaging :

Approval Date :

Application Number : 103951

Regulatory Info :

Registration Country : USA

blank

10

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : VIAL; SUBCUTANEOUS

Dosage Strength : 200UG/ML

Packaging :

Approval Date :

Application Number : 103951

Regulatory Info :

Registration Country : USA

blank

11

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Darbepoetin alfa

Brand Name : Aranesp SureClick

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

12

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Darbepoetin alfa

Brand Name : Aranesp SureClick

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

13

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Darbepoetin alfa

Brand Name : Aranesp

Dosage Form : injection

Dosage Strength : 100 microgram/0.5 mL

Packaging : 4

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

14

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Darbepoetin alfa

Brand Name : Aranesp

Dosage Form : injection

Dosage Strength : 10 microgram/0.4 mL

Packaging : 4

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

15

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Darbepoetin alfa

Brand Name : Aranesp

Dosage Form : injection

Dosage Strength : 20 microgram/0.5 mL

Packaging : 4

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

16

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Darbepoetin alfa

Brand Name : Aranesp

Dosage Form : injection

Dosage Strength : 30 microgram/0.3 mL

Packaging : 4

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

17

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Darbepoetin alfa

Brand Name : Aranesp

Dosage Form : injection

Dosage Strength : 40 microgram/0.4 mL

Packaging : 4

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

18

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Darbepoetin alfa

Brand Name : Aranesp

Dosage Form : injection

Dosage Strength : 50 microgram/0.5 mL

Packaging : 4

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

19

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Darbepoetin alfa

Brand Name : Aranesp

Dosage Form : injection

Dosage Strength : 60 microgram/0.3 mL

Packaging : 4

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

20

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Darbepoetin alfa

Brand Name : Aranesp

Dosage Form : injection

Dosage Strength : 100 microgram/0.5 mL

Packaging : 4

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank